超声造影评估甲状腺乳头状癌被膜外侵犯的研究进展  

Research progress of contrast-enhanced ultrasound in assessing ETE of papillary thyroid carcinoma

作　　者：陈启阳 胡向东[1] CHEN Qi-yang;HU Xiang-dong(Department of Ultrasound,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China)

机构地区：[1]首都医科大学附属北京友谊医院超声科,北京100050

出　　处：《中国医学装备》2021年第11期188-192,共5页China Medical Equipment

基　　金：工信部先进医疗装备应用示范项目(2018MND102015)“彩色多普勒超声诊断系统应用示范项目(甲状腺成像体系超声评价规范)”;北京友谊医院院启动课题(yyqdkt2018-2)“多模态超声影像对意义不明确的甲状腺结节的诊断价值”。

摘　　要：乳头状癌是甲状腺癌最常见的病理类型,预后往往较好,但部分甲状腺乳头状癌(PTC)会出现被膜外侵犯(ETE),影响治疗方式且导致患者预后较差。对比增强超声(CEUS)(超声造影)能够定性、定量评估病灶内部微血管灌注情况,并可显示被膜增强的连续性,能够为评估是否存在ETE提供有价值的信息。通过综述CEUS的优势及其在评估ETE中的研究进展,进一步阐述CEUS评估ETE的应用价值。Papillary carcinoma is the most common pathological type of thyroid carcinoma,and its prognosis is better in most cases.However,a portion of papillary thyroid carcinomas(PTC)would occur extrathyroidal extension(ETE),which could affect the treatment method and lead to poor prognosis of patients.Contrast-enhanced ultrasound(CEUS)can qualitatively and quantitatively assess the microvascular perfusion inside of the lesion and can show the continuity of capsule enhancement.Therefore,it can provide valuable information for assessing whether existing ETE.This paper further stated the application value of CEUS in assessing ETE through reviewed the advantages of CEUS and its research progress in assessing ETE.

关 键 词：超声造影(CEUS) 甲状腺乳头状癌(PTC) 被膜外侵犯(ETE) 

分 类 号：R445.1[医药卫生—影像医学与核医学]